MicroRNA-144 silencing attenuates intimal hyperplasia by directly targeting PTEN
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Hypertension"
DOI: 10.1080/10641963.2022.2123923
Abstract: ABSTRACT Background Intimal hyperplasia contributed by phenotypic switching of vascular smooth muscle cell (VSMC) plays an important role in the pathogenesis of various cardiovascular diseases. MicroRNA-144 (miR-144) is recently reported to be implicated in the… read more here.
Keywords: microrna 144; targeting pten; mir 144; intimal hyperplasia ... See more keywords
LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.16199
Abstract: Pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide. Liver kinase B1 interacting protein 1 (LKB1IP) was identified as the binding protein of tumour suppressor LKB1. However, the role of LKB1IP in… read more here.
Keywords: cardiac hypertrophy; lkb1ip; hypertrophy; pathological cardiac ... See more keywords
microRNA-222 promotes tumor growth and confers radioresistance in nasopharyngeal carcinoma by targeting PTEN.
Sign Up to like & getrecommendations! Published in 2018 at "Molecular medicine reports"
DOI: 10.3892/mmr.2017.7931
Abstract: MicroRNA-222 (miR‑222) has been reported to be involved in the initiation, development and metastasis of tumors, as well as conferring resistance to chemotherapeutic drugs or radiotherapy in various types of cancer. However, the role and… read more here.
Keywords: mir 222; cell lines; microrna 222; nasopharyngeal carcinoma ... See more keywords